Asia’s “nascent capital market” needs a catalyst — but investors shouldn’t be deterred from investing in the region’s private ...

As most followers of the PIMCO Dynamic Income Strategy fund (PDX) know, the rapid-growth trajectory of the fund has been ...

Analysts say outlook is good after uneven trading start; leaders Sabel and Pender see windfall from stock listing ...

SailPoint, which has tapped 19 banks for the IPO, will list on the Nasdaq under the symbol "SAIL". Thoma Bravo will own about ...

The company launched the IPO after doubling revenue in 2024, driven by increased oil production from well acquisitions worth ...

SailPoint is targeting a valuation of up to US$11.5 billion ($18.4 billion) in its New York flotation, as the cyber security ...

Bernstein initiated coverage of Venture Global (NYSE:VG), a $51.9 billion market cap LNG company, with a Market Perform rating and set a price target of $20.00. The research firm sees a modest 2% ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...